Thomas B. Smith
Executive VP & Chief Medical OfficerDr. Thomas B. Smith, also known as Tom, M.D. FAAFP, has served as Chief Medical Officer of Collegium Pharmaceutical, Inc. since March 2022 and serves as its Executive Vice President. Dr. Smith served as Chief Medical Officer of BioDelivery Sciences International, Inc. since July 30, 2018 until March 2022. Dr. Smith joined the Collegium Pharmaceutical, Inc. on March 23, 2022. Dr. Smith was Chief Medical Officer at Charleston Laboratories, Inc. since January 24, 2017 until July 2018. Dr. Smith has experience from his time in a variety of leadership roles at various major pharmaceutical companies, including Chief Medical Officer at Ameritox, Mallinckrodt and Covidien and as a clinical investigator and private practitioner. Dr. Smith is working closely with various global medical and regulatory agencies to implement these strategies. Dr. Smith served as the Chief Medical Officer of Ameritox, Ltd. since October 17, 2014 until January 2017. Dr. Smith served as Chief Medical Officer for Mallinckrodt Pharmaceuticals from 2012 to 2014. Dr. Smith has held clinical leadership roles at Abbott Laboratories, Teva Pharmaceuticals, Kendle International, Akros Pharma and Genzyme during 2001 to 2014. Dr. Smith served as Global medical Director of Kendle International Inc. since March 16, 2007 and its Vice President of Medical Affairs since July 25, 2007. Dr. Smith has a significant experience in CNS drug development, having led a clinical team in the preparation and submission of an Investigational New Drug (IND) for a novel compound for Alzheimer's disease. He also was involved in the successful filing of a supplemental new drug application (sNDA) of Depakote(R) ER for bipolar mania to the United States Food and Drug Administration. He has a nearly 20 years of pharmaceutical industry experience. He served as Senior Director, Clinical Research and Development of Akros Pharma Inc. he was responsible for assisting in the implementation and execution of clinical studies and for the preparation of clinical sections of regulatory submissions for new products and therapies. He served as Medical Director, Global Research and Development of Genzyme Corporation and Associate Medical Director, Neuroscience Development of Abbott Laboratories. His extensive and wide-ranging roles include having been Chief Medical Officer at various leading pain companies, head of medical affairs at top tier pharma and CRO companies, as well as running his own private practice. Dr. Smith is a highly published scientific author and has delivered more than 150 presentations in his field of expertise. Dr. Smith's background includes working across all phases of drug development and the full spectrum of therapeutic areas, numerous disease states, with significant expertise in CNS, renal and metabolic disorders. A widely-published author, Dr. Smith also has delivered more than 150 scientific presentations. He is a member of the American Medical Association, American Academy of Family Physicians and the American Council for Headache Education. Dr. Smith earned a Doctor of Medicine from Indiana University School of Medicine and a Bachelor of Science from Purdue University.
Positions
- Company NameCollegium Pharmaceutical, Inc.Stock CodeCOLLPositionExecutive VP & Chief Medical OfficerColleagues
- VKVikram KarnaniCEO, President & Director
- GSGino SantiniIndependent Chairman
- CTColleen TupperExecutive VP & CFO
- DDDavid DieterExecutive VP, General Counsel & Corporate Secretary
- IKIan KarpHead of Investor Relations
- GGGaren G. BohlinIndependent Director
- RJRita J. Balice-GordonIndependent Director
- NSNancy S. LurkerIndependent Director
